• Apigenin: Optimized Protocols for Cancer & Neuroprotection R

  2026-05-09

  Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) enables precision targeting of HDAC-mediated apoptosis in oncology and advanced neuroprotection assays in Alzheimer’s models. This guide translates network pharmacology insights and rigorous workflow data into actionable steps, troubleshooting, and practical advantages for applied research.

• EZ Cap™ Firefly Luciferase mRNA: Precision Reporter & Workfl

  2026-05-08

  EZ Cap™ Firefly Luciferase mRNA stands apart with its Cap 1 structure and optimized poly(A) tail, delivering superior stability and translation efficiency for reporter assays. Explore experimental workflows, advanced applications, and evidence-based troubleshooting to maximize signal fidelity and reproducibility in molecular biology research.

• Foxp1 Suppresses PTH-Induced Valvular Calcification in CKD M

  2026-05-08

  This study reveals that endothelial overexpression of Foxp1 inhibits parathyroid hormone (PTH)-driven endothelial-to-mesenchymal transition (EndMT), chiefly by repressing Notch pathway activation, and thereby attenuates valvular calcification in chronic kidney disease (CKD) models. The findings delineate a mechanistic link between Foxp1, the Jagged-1/Notch axis, and calcific valve pathology, offering new targets for translational intervention.

• GLP-1 (9-36) amide: Precision Antagonism in Receptor Signali

  2026-05-07

  GLP-1 (9-36) amide sets the benchmark for dissecting glucagon-like peptide-1 receptor signaling with unrivaled specificity, enabling robust workflows in metabolic and type 2 diabetes research. This guide translates advanced FRET assay insights and recent evidence into practical protocols and troubleshooting strategies for reproducible results.

• hiPSC-Derived Intestinal Organoids for Human Pharmacokinetic

  2026-05-07

  This study details a streamlined protocol for generating human intestinal organoids from pluripotent stem cells, providing a more physiologically relevant in vitro model for pharmacokinetic and gastrointestinal research. The work addresses limitations of traditional cell lines and animal models, enabling advanced studies of drug metabolism and absorption.

• Cyclo (-RGDfC) in High-Throughput Hydrogel Systems: Integrin

  2026-05-06

  Explore how Cyclo (-RGDfC) empowers integrin αvβ3 targeting in next-generation, high-throughput hydrogel and cell-based assays. This article uniquely bridges peptide biochemistry with innovative hydrogel printing, revealing new best practices for cancer and angiogenesis research.

• Bradykinin B2 Receptors Inhibit Ileal Peristalsis in Guinea

  2026-05-06

  This study provides the first direct evidence that bradykinin B2 receptors mediate an inhibitory effect on the peristaltic reflex in the guinea pig ileum. By using selective agonists and antagonists, the research clarifies receptor-specific modulation of gastrointestinal motility, with significant implications for hypertension and ACE inhibitor research.

• CBD Reduces Orofacial Pain via Cannabinoid and Serotonin Pat

  2026-05-05

  This study demonstrates that cannabidiol (CBD) robustly attenuates both the sensory and affective dimensions of orofacial inflammatory pain in murine models, via coordinated modulation of endocannabinoid and serotonergic signaling. The findings highlight the therapeutic potential of CBD for multidimensional pain management, paving the way for new translational strategies in chronic pain and related affective disorders.

• Adipose-Neural Axis Drives Cardiac Arrhythmias via Leptin-NP

  2026-05-05

  Fan et al. (2024) reveal that epicardial adipose tissue (EAT) contributes to cardiac arrhythmogenesis by activating a leptin–neuropeptide Y (NPY) neural circuit, which modulates cardiomyocyte excitability. Their stem cell-based coculture model identifies the NPY/Y1 receptor axis as a potential intervention target, highlighting new therapeutic directions for atrial fibrillation and related arrhythmias.

• Triptolide (PG490): Precision Workflows in Cancer & Immunolo

  2026-05-04

  Triptolide (PG490) empowers researchers with nanomolar potency and multifaceted suppression of tumor cell proliferation, immune signaling, and inflammatory mediators. This article translates cutting-edge mechanistic insights and the latest workflow guidance into actionable protocols, troubleshooting strategies, and advanced applications for oncology and immunology labs.

• Cdk5 Inhibition Mitigates Neuronal Ferroptosis via AMPK and

  2026-05-04

  This study reveals that downregulating Cdk5 in ischemic stroke models reduces hippocampal neuron ferroptosis by modulating AMPK signaling and microglial polarization. The findings provide mechanistic insight into the intersection of neuroinflammation, iron metabolism, and cell death, suggesting new avenues for therapeutic intervention.

• GS-441524 Prodrug: Conversion Pathways, Solubility, and Phar

  2026-05-03

  Explore the mechanisms and advanced pharmacokinetic insights of GS-441524, a leading nucleoside analog in antiviral research. This article goes beyond established protocols, revealing conversion pathways and solubility challenges that inform next-generation assay and drug development.

• BIBP 3226 trifluoroacetate: Reliable NPY/NPFF Antagonist for

  2026-05-02

  This article addresses real laboratory challenges in cell viability, proliferation, and neuropeptide signaling assays by demonstrating how BIBP 3226 trifluoroacetate (SKU B7155) offers reproducible, data-backed solutions. Through scenario-driven Q&A, we explore its unique advantages for NPY/NPFF system research and guide biomedical scientists in optimizing experimental reliability and workflow efficiency.

• AP20187: Chemical Inducer of Dimerization for Precision Gene

  2026-05-01

  AP20187 empowers researchers to achieve tunable, reversible activation of signaling pathways through precise protein dimerization, making it indispensable for conditional gene therapy and metabolic research. Its high purity, solubility, and robust validation in both in vitro and in vivo models elevate experimental reliability and translational impact.

• Cyclo (-RGDfC): Advancing Integrin-Driven Tumor Targeting

  2026-05-01

  This thought-leadership piece explores Cyclo (-RGDfC), a cyclic RGD peptide, as a precision tool for translational oncology and angiogenesis research. By blending mechanistic insights with actionable experimental guidance, it contextualizes the peptide’s value in the light of recent advances in digital hydrogel platforms and high-throughput workflows, while offering a strategic perspective for researchers looking to maximize the translational impact of integrin αvβ3 targeting.

16171 records 1/1079 page Next 12345 下5页 Last page